ProfileGDS4718 / 227408_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 81% 79% 70% 80% 88% 82% 77% 84% 79% 81% 81% 79% 84% 84% 77% 79% 80% 77% 74% 73% 72% 82% 76% 74% 82% 79% 87% 83% 85% 79% 87% 82% 81% 86% 88% 76% 81% 81% 82% 80% 87% 84% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7679579
GSM549102patient 115, normal, homogenized [OPG study]7.9188781
GSM549104patient 119, normal, homogenized [OPG study]7.7691279
GSM549108patient 138, normal, homogenized [OPG study]6.8279470
GSM549119patient 077, normal, homogenized [OPG study]7.7350480
GSM549133patient 032, cancer, homogenized [OPG study]8.9562288
GSM549139patient 042, cancer, homogenized [OPG study]8.1104582
GSM549099patient 107, normal, homogenized [OPG study]7.4956177
GSM549109patient 139, normal, homogenized [OPG study]8.3373584
GSM549110patient 046, normal, homogenized [OPG study]7.7374379
GSM549114patient 063, normal, homogenized [OPG study]8.0908581
GSM549122patient 082, normal, homogenized [OPG study]7.9033881
GSM549134patient 033, cancer, homogenized [OPG study]7.8082579
GSM549136patient 036, cancer, homogenized [OPG study]8.3779484
GSM549140patient 044, cancer, homogenized [OPG study]8.4082884
GSM549111patient 047, normal, homogenized [OPG study]7.5354477
GSM549113patient 057, normal, homogenized [OPG study]7.8210979
GSM549132patient 031, cancer, homogenized [OPG study]7.819580
GSM549137patient 038, cancer, homogenized [OPG study]7.5783477
GSM549142patient 047, cancer, homogenized [OPG study]7.1445174
GSM549100patient 110, normal, homogenized [OPG study]7.1108973
GSM549107patient 135, normal, homogenized [OPG study]7.0316772
GSM549115patient 068, normal, homogenized [OPG study]8.2609882
GSM549116patient 072, normal, homogenized [OPG study]7.4657476
GSM549120patient 078, normal, homogenized [OPG study]7.2403374
GSM549131patient 030, cancer, homogenized [OPG study]8.1881482
GSM549118patient 074, normal, homogenized [OPG study]7.7940379
GSM549129patient 027, cancer, homogenized [OPG study]8.6101387
GSM549123patient 088, normal, homogenized [OPG study]8.1724383
GSM549124patient 006, cancer, homogenized [OPG study]8.4119185
GSM549126patient 015, cancer, homogenized [OPG study]7.71379
GSM549128patient 025, cancer, homogenized [OPG study]8.8041187
GSM549103patient 117, normal, homogenized [OPG study]7.9149282
GSM549117patient 073, normal, homogenized [OPG study]8.0313481
GSM549138patient 041, cancer, homogenized [OPG study]8.6622986
GSM549141patient 045, cancer, homogenized [OPG study]9.0069588
GSM549130patient 028, cancer, homogenized [OPG study]7.4233476
GSM549101patient 111, normal, homogenized [OPG study]7.8934381
GSM549105patient 128, normal, homogenized [OPG study]7.9376781
GSM549106patient 134, normal, homogenized [OPG study]8.3005282
GSM549112patient 048, normal, homogenized [OPG study]7.8263280
GSM549125patient 011, cancer, homogenized [OPG study]8.6332987
GSM549127patient 024, cancer, homogenized [OPG study]8.3216584
GSM549135patient 035, cancer, homogenized [OPG study]9.4634391